Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic Vascular
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must be an acceptable candidate for percutaneous coronary intervention (PCI), stenting, and emergent coronary artery bypass graft (CABG) surgery
Must have clinical evidence of ischemic heart disease, stable or unstable angina, and/or a positive functional study
Must require treatment of either a) a single target lesion amenable to treatment OR b) two target lesions located in separate target vessels
Target lesion(s) must be de novo lesion(s) in native coronary artery(ies)
You may not be if
Known hypersensitivity or contraindication to aspirin, heparin and bivalirudin, thienopyridines, cobalt, nickel, platinum, iridium, chromium, molybdenum, polymer coatings (e.g. BioLinx) or a sensitivity to contrast media, which cannot be adequately pre-medicated
History of an allergic reaction or significant sensitivity to drugs such as zotarolimus, rapamycin, tacrolimus, everolimus, or any other analogue or derivative
History of a stroke or transient ischemic attack (TIA) within the prior 6 months
Active peptic ulcer or upper gastrointestinal (GI) bleeding within the prior 6 months
History of bleeding diathesis or coagulopathy or will refuse blood transfusions
Concurrent medical condition with a life expectancy of less than 12 months
Currently participating in an investigational drug or another device trial that has not completed the primary endpoint
Documented left ventricular ejection fraction (LVEF) \< 30% at the most recent evaluation
